Previous Article | Next Article ![]()
Journal of Virology, December 2005, p. 14546-14554, Vol. 79, No. 23
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.23.14546-14554.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Pathology,1 Department of Pediatrics,3 Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas 77555,4 Children's Hospital Research Foundation, Cincinnati, Ohio 452292
Received 5 July 2005/ Accepted 16 September 2005
The T-cell-mediated resolution of herpes simplex virus type 2 (HSV-2) genital infections is not fully understood. In these studies, the mechanisms by which CD8+ T cells clear virus from the genital epithelium were examined. Ovalbumin (OVA)-specific CD8+ T cells from OT-I transgenic mice cleared a thymidine kinase-deficient, ovalbumin-expressing HSV-2 virus (HSV-2 tk OVA) from the genital epithelium of recipient mice, and clearance was abrogated by in vivo neutralization of gamma interferon (IFN-
). Further, CD8+ OT-I T cells deficient in IFN-
were unable to clear HSV-2 tk OVA from the vaginal epithelium. The requirement for cytolytic mechanisms in HSV-2 tk OVA clearance was tested in radiation chimeras by adoptive transfer of wild-type or perforin-deficient OT-I T cells to irradiated Fas-defective or wild-type recipients. Although a dramatic decrease in viral load was observed early after challenge with HSV-2 tk OVA, full resolution of the infection was not achieved in recipients lacking both perforin- and Fas-mediated cytolytic pathways. These results suggest that IFN-
was responsible for an early rapid decrease in HSV-2 virus titer. However, either perforin- or Fas-mediated cytolytic mechanisms were required to achieve complete clearance of HSV-2 from the genital epithelium.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|